Search Results

PSI-6206 10mg  | ≥99%

CSNpharm

PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.

More Information Supplier Page

PSI-6206 50mg  | ≥99%

CSNpharm

PSI-6206, the deaminated derivative of PSI-6130, is a selective inhibitor of HCV NS5B polymerase and the EC50 for inhibition of HCV replicon is > 100 μM.

More Information Supplier Page

BGP-15 10mg  | ≥99%

CSNpharm

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

More Information Supplier Page

Ziprasidone HCl H2O 50mg  | ≥99%

CSNpharm

Ziprasidone HCl H2O is a full antagonist of D2 receptors and of 5-HT2A receptors and is a partial agonist of 5-HT1A receptors, of 5-HT2C receptors and 5-HT1D receptors, used as an atypical antipsychoticfor the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder.

More Information Supplier Page

Ziprasidone HCl H2O 10mg  | ≥99%

CSNpharm

Ziprasidone HCl H2O is a full antagonist of D2 receptors and of 5-HT2A receptors and is a partial agonist of 5-HT1A receptors, of 5-HT2C receptors and 5-HT1D receptors, used as an atypical antipsychoticfor the treatment of schizophrenia as well as acute mania and mixed states associated with bipolar disorder.

More Information Supplier Page

Closantel 250mg  | ≥99%

CSNpharm

Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.

More Information Supplier Page

Closantel 25mg  | ≥99%

CSNpharm

Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.

More Information Supplier Page

Closantel 100mg  | ≥99%

CSNpharm

Closantel is a salicylanilide anthelmintic compound and exhibits different anthelmintic spectra and apparent toxicity in mammals.

More Information Supplier Page

BGP-15 1mg  | ≥99%

CSNpharm

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

More Information Supplier Page

BGP-15 25mg  | ≥99%

CSNpharm

BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has been demonstrated that BGP-15 protects against ischemia-reperfusion injury.

More Information Supplier Page